TNFSF10 and pancreatic neoplasm: It remains to be studied whether the machinery required for the formation of the DcR3-TRAIL complex is fully possessed by AsPC-1 pancreatic cancer cells but is missing in TRAIL-Fc overexpressing 293 cells, which might account for the different binding phenotypes.